NCT05804305View on ClinicalTrials.gov

Misoprostol for NASH

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
NASH
Interventions
DRUG

Misoprostol

Misoprostol is a prostaglandin E1 analogue

DRUG

Placebo

Placebo contained substance that has no therapeutic value.

Trial Locations (1)

75600

Dr. Ziauddin Hospital Clifton, Karachi

All Listed Sponsors
collaborator

Nabiqasim Industries (Pvt) Ltd

INDUSTRY

lead

Ziauddin University

OTHER